Website
N/ATelephone
64.3.479.5800
Address
87 St. David Street Centre for Innovation Dunedin, Otago 9016
Description
Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in the Commercial and Research segments. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide. The Research segment engages in the research and development of diagnostic and prognostic products for human cancer. The company was founded on February 27, 2001 and is headquartered in Dunedin, New Zealand.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.08 - 0.49
Trade Value (12mth)
AU$2,276.00
1 week
-11.35%
1 month
-14.58%
YTD
-82.92%
1 year
-80.24%
All time high
1.605
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
811m
HALO Sector
Healthcare
Next Company Report Date
23-May-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 March 23 |
Pacific Edge Provides Update on Kaiser EMR Integration
×
Pacific Edge Provides Update on Kaiser EMR Integration |
30 March 22 |
PEB Investor Update - March 2022
×
PEB Investor Update - March 2022 |
29 July 22 |
Pacific Edge 2022 Annual Shareholders Meeting - Results
×
Pacific Edge 2022 Annual Shareholders Meeting - Results |
29 July 22 |
Pause in Trading
×
Pause in Trading |
29 July 22 |
Trading Halt
×
Trading Halt |
28 July 23 |
Letter to Shareholders
×
Letter to Shareholders |
28 July 22 |
Pacific Edge Appoints Chief Operating Officer
×
Pacific Edge Appoints Chief Operating Officer |
28 July 22 |
Pacific Edge 2022 Annual Shareholders Meeting
×
Pacific Edge 2022 Annual Shareholders Meeting |
28 April 22 |
D&O Disclosure - NZX - D Darling
×
D&O Disclosure - NZX - D Darling |
27 July 23 |
Chair's Address to Shareholders
×
Chair's Address to Shareholders |
27 July 23 |
Pacific Edge 2023 Annual Shareholder Meeting - Results
×
Pacific Edge 2023 Annual Shareholder Meeting - Results |
26 May 22 |
PEB FY22 Result - NZX Announcement Template
×
PEB FY22 Result - NZX Announcement Template |
26 May 22 |
Pacific Edge LTD FY22 Result
×
Pacific Edge LTD FY22 Result |
26 June 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
26 April 22 |
Application for quotation of securities - PEB
×
Application for quotation of securities - PEB |
26 April 22 |
Capital Change Notice - NZX
×
Capital Change Notice - NZX |
25 October 23 |
NZX - Capital Change Notice
×
NZX - Capital Change Notice |
25 October 23 |
NZX - D&O Disclosures - P Meintjes & G Gibson - 25 Oct 23
×
NZX - D&O Disclosures - P Meintjes & G Gibson - 25 Oct 23 |
25 October 23 |
Notification regarding unquoted securities - PEB
×
Notification regarding unquoted securities - PEB |
25 May 23 |
Pacific Edge Delivers on Growth Strategy in FY 2023
×
Pacific Edge Delivers on Growth Strategy in FY 2023 |
24 November 22 |
Financial Results for the Half Year to 30 September 2022
×
Financial Results for the Half Year to 30 September 2022 |
23 September 22 |
Update on Te Whatu Ora Southern Commercial Agreement
×
Update on Te Whatu Ora Southern Commercial Agreement |
23 November 23 |
Financial Results for the Half Year to 30 September 2023
×
Financial Results for the Half Year to 30 September 2023 |
23 May 22 |
Director Nomination Closing Date
×
Director Nomination Closing Date |
22 May 23 |
Director Nomination Closing Date
×
Director Nomination Closing Date |
22 June 23 |
Annual Report to shareholders
×
Annual Report to shareholders |
22 June 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
22 June 22 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.